| Literature DB >> 28116527 |
Seung-Min Hong1, Hyuk-Joon Kwon2,3, Kang-Seuk Choi4, Jae-Hong Kim5,6.
Abstract
To minimize the spread of infectious bronchitis virus (IBV), domestic fowl have been extensively vaccinated with the KM91 strain. However, various IBV QX-like virus strains have become increasingly prevalent in Korea. We conducted comparative genomic analyses of seven QX-like viruses: early viruses (n = 2), new cluster 1 (NC1; recombinants of KM91 and the early QX-like viruses, n = 3) and recurrent viruses (n = 2), to understand their genomic backgrounds. The early and NC1 viruses had KM91-like backgrounds, but the recurrent viruses had QX-like genomic backgrounds. The absence of pure QX-like viruses before the appearance of the early viruses suggests that the viruses were introduced from other countries after recombination, but the NC1 viruses originated in Korea. The recent prevalence of recurrent viruses with different genomic backgrounds and spike genes from the early and the NC1 viruses may indicate the repeated introduction of different infectious bronchitis viruses from other countries and their successful evasion of vaccine immunity in the field. Furthermore, a 1ab gene-based phylogenetic analysis revealed three distinct lineages: North America-Europe, China/Taiwan, and China. KM91 and the early and NC1 viruses were included in the North America-Europe lineage, and the recurrent QX-like viruses were included in the China lineage. The phylogenetic positions of KM91-like 1ab and QX-like spike suggest frequent recombination between the North America-Europe and China lineages. Additional studies on the patterns of recombination, including donor-acceptor relationships, geographical sites, and non-poultry hosts, may be valuable for understanding the evolution of IBVs.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28116527 PMCID: PMC7087172 DOI: 10.1007/s00705-016-3208-x
Source DB: PubMed Journal: Arch Virol ISSN: 0304-8608 Impact factor: 2.574
Fig. 2Phylogenetic trees based on: 1.5 kb nucleotide sequences of S1 (a), full genome (b), and 1ab genes (c), were constructed with the neighbor-joining method using MEGA 5.05. The bootstrap values were determined from 1000 replicates of the original data. The branch number represents the percentage of times that the branch appeared in the tree. Bootstrap values greater than 90% are shown. The p-distance is indicated by the bar at the bottom of the figure. The QX-like viruses characterized in the present study are marked with closed circles
Genome size, GC content, and IBV proteins with differing amino acid lengths for the examined QX-like viruses
| QIA-03342 | QIA-KR/D79/05 | QIA-Q43 | SNU9106 | SNU-10043 | SNU-8065 | SNU11045 | |
|---|---|---|---|---|---|---|---|
| Full length | 27,684 | 27,682 | 27,675 | 27,684 | 27,683 | 27,679 | 27,679 |
| G + C content | 38.08% | 38.2% | 38.08% | 38.23% | 38.13% | 38.16% | 38.14% |
| S | 1,165 | 1,165 | 1,163 | 1,165 | 1,165 | 1,165 | 1,165 |
| 3b | 65 | 65 | 65 | 65 | 65 | 62 | 62 |
| E | 109 | 109 | 109 | 109 | 109 | 108 | 108 |
| M | 226 | 226 | 226 | 226 | 226 | 225 | 225 |
Nucleotide and amino acid identities (%) of QX-like viruses, when compared to KM91 and YX10
| Nucleotide and amino acid identity (nt/aa; %) | ||||||||
|---|---|---|---|---|---|---|---|---|
| QIA- | QIA-D79/05 | QIA-Q43/06 | SNU- | SNU-10043 | SNU- | SNU-11045 | ||
| Genome | KM91 | 95 | 95 | 96 | 96 | 95 | 87 | 87 |
| YX10 | 88 | 88 | 88 | 88 | 88 | 98 | 98 | |
| 5′-UTR | KM91 | 99 | 98 | 99 | 99 | 99 | 95 | 94 |
| YX10 | 95 | 94 | 95 | 94 | 95 | 99 | 99 | |
| 1ab | KM91 | 97/97 | 96/97 | 96/97 | 96/97 | 96/97 | 87/91 | 87/91 |
| YX10 | 87/91 | 87/91 | 87/91 | 87/91 | 87/91 | 98/99 | 98/99 | |
| S1 | KM91 | 85/86 | 85/85 | 90/90 | 92/90 | 91/91 | 85/85 | 85/85 |
| YX10 | 96/95 | 95/94 | 91/89 | 88/88 | 88/89 | 98/98 | 98/98 | |
| S2 | KM91 | 92/94 | 94/94 | 98/97 | 98/97 | 93/93 | 93/95 | 93/95 |
| YX10 | 80/71 | 80/71 | 80/71 | 79/71 | 78/70 | 99/100 | 99/100 | |
| 3a | KM91 | 63/52 | 63/52 | 63/52 | 63/52 | 62/50 | 72/69 | 72/69 |
| YX10 | 74/63 | 74/63 | 74/63 | 75/65 | 76/66 | 100/100 | 100/100 | |
| 3b | KM91 | 80/72 | 80/72 | 80/72 | 80/72 | 81/74 | 74/67 | 74/67 |
| YX10 | 86/85 | 87/85 | 86/85 | 85/83 | 86/84 | 99/99 | 99/99 | |
| E | KM91 | 98/100 | 97/98 | 99/100 | 97/96 | 94/95 | 86/85 | 86/85 |
| YX10 | 86/85 | 87/85 | 86/85 | 85/83 | 86/84 | 99/99 | 99/99 | |
| M | KM91 | 94/96 | 96/98 | 94/95 | 95/96 | 98/100 | 89/93 | 89/93 |
| YX10 | 90/94 | 91/94 | 90/93 | 89/92 | 89/94 | 99/99 | 99/99 | |
| 4b | KM91 | 85/82 | 93/94 | 85/82 | 94/93 | 85/81 | 89/87 | 89/87 |
| YX10 | 85/84 | 90/91 | 85/84 | 89/87 | 85/83 | 100/100 | 100/100 | |
| 4c | KM91 | 88/77 | 87/74 | 8877 | 87/72 | 88/77 | 71/53 | 7153 |
| YX10 | 75/58 | 74/53 | 74/58 | 74/58 | 75/58 | 100/100 | 100/100 | |
| 5a | KM91 | 96/97 | 97/98 | 95/95 | 95/92 | 94/94 | 83/83 | 83/83 |
| YX10 | 83/85 | 83/85 | 81/81 | 82/81 | 80/80 | 98/98 | 98/98 | |
| 5b | KM91 | 97/93 | 99/98 | 98/95 | 98/94 | 99/98 | 91/88 | 91/88 |
| YX10 | 93/91 | 92/90 | 92/90 | 92/90 | 93/91 | 93/88 | 92/88 | |
| N | KM91 | 97/97 | 97/97 | 97/96 | 97/97 | 97/97 | 89/92 | 89/92 |
| YX10 | 88/92 | 88/92 | 88/92 | 88/92 | 88/92 | 88/92 | 88/92 | |
| 6b | KM91 | 97/96 | 96/93 | 94/92 | 97/95 | 100/100 | 84/78 | 85/77 |
| YX10 | 84/81 | 83/78 | 81/77 | 84/80 | 84/78 | 96/95 | 95/93 | |
| 3′-UTR | KM91 | 98 | 97 | 96 | 95 | 98 | 84 | 85 |
| YX10 | 83 | 82 | 80 | 80 | 82 | 95 | 96 | |
Nonstructural protein (nsp) amino acid identities between the QX-like viruses and KM91 and YX10
| NSP | Putative functionb | Protease* | Size (aa) | Amino acid identity with respect to KM91/YX10 (%) | Percent differencesb | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| QIA-03342 | QIA-D79/05 | QIA-Q43/06 | SNU-9106 | SNU-10043 | SNU-8065 | SNU-11045 | |||||
| 2 | Unknown | PLP | 673 | 95/85 | 96/86 | 96/86 | 95/86 | 95/86 | 86/98 | 86/98 | 9–12% |
| 3 | Papain-like viral protease | PLP | 1,594 | 95/86 | 95/86 | 94/85 | 94/85 | 94/85 | 84/98 | 84/98 | 9–14% |
| 4 | Unknown | PLP/3CLpro | 514 | 98/88 | 98/89 | 98/89 | 98/88 | 97/88 | 87/100 | 87/100 | 9–13% |
| 5 | Coronavirus endopeptidase C30 | 3CLpro | 307 | 98/91 | 98/90 | 98/91 | 97/90 | 98/90 | 89/99 | 90/99 | 7–10% |
| 6 | Hydrophobic domain | 3CLpro | 293 | 99/86 | 99/87 | 97/86 | 98/87 | 98/86 | 87/99 | 87/99 | 11–13% |
| 7 | nsp7 superfamily | 3CLpro | 83 | 100/98 | 99/96 | 99/96 | 99/96 | 96/94 | 96/99 | 96/99 | 2–4% |
| 8 | nsp8 superfamily | 3CLpro | 210 | 98/94 | 99/93 | 99/93 | 98/93 | 97/92 | 94/98 | 94/98 | 4–6% |
| 9 | nsp9 superfamily | 3CLpro | 111 | 100/100 | 100/100 | 100/100 | 100/100 | 100/100 | 98/98 | 100/100 | 0–2% |
| 10 | nsp10 superfamily, RNA synthesis | 3CLpro | 145 | 97/94 | 99/96 | 97/94 | 98/94 | 99/95 | 95/100 | 94/99 | 3–5% |
| 12 | RNA-dependent RNA polymerase | 3CLpro | 940 | 99/96 | 99/96 | 98/96 | 99/96 | 98/96 | 96/99 | 96/99 | 2–3% |
| 13 | Viral RNA helicase | 3CLpro | 600 | 98/97 | 98/97 | 99/97 | 99/98 | 99/98 | 97/100 | 97/99 | 1–3% |
| 14 | nsp11 superfamily; exoribonuclease | 3CLpro | 521 | 99/97 | 99/97 | 99/97 | 99/97 | 98/97 | 97/99 | 97/99 | 2% |
| 15 | Nidoviral uridylate-specific endoribonuclease | 3CLpro | 338 | 97/95 | 97/95 | 98/95 | 96/94 | 96/93 | 94/96 | 94/96 | 2–3% |
| 16 | 23S rRNA methylase | 3CLpro | 302 | 99/96 | 99/96 | 98/97 | 98/96 | 98/96 | 96/99 | 96/99 | 1–3% |
*PLP, papain-like protease; 3CLpro, 3C-like protease; b difference between identities with respect to KM91 and YX10
Comparison of the transcription regulatory sequences (TRSs) in the full IBV genomes
| Sg mRNA | TRS | KM91 | Sequence and location of TRS | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| QIA-03342 | QIA-KR/D79/05 | QIAQ-43/06 | SNU9106 | SNU10043 | YX10 | SNU8065 | SNU11045 | |||
| Leader | CTTAACAA (57-64) | CTTAACAA (57-64) | CTTAACAA (57-64) | CTTAACAA (57-64) | CTTAACAA (57-64) | CTTAACAA ((57-64) | CTTAACAA (57-64) | CTTAACAA (57-64) | CTTAACAA (57-64) | |
| 1(S) | Body | AAG----- (20,311-20,318) | AGG----- (20,314-20,321) | AGG----- (20,314-20,321) | AAG----- (20315-20322) | T–T----- (20,314-20,321) | AGG----- (20316-20323) | --G----- (20,311-20,318) | --G----- (20315-20322) | --G----- (20,314-20,321) |
| 2(3ab) | Body | --G----- (23,831-23,838) | --G----- (23840-23847) | --G----- (23840-23847) | --G----- (23835-23842) | --G----- (23840-23847) | --G----- (20342-23849) | -------- (23837-23844) | --G----- (23835-23842) | --G----- (23,838-23,845) |
| 3(E) | Body | --C----- (24,035-24,042) | T-C----- (24088-24094) | T-C----- (24087-24094) | T-C----- (24082-24089) | T-C----- (24087-24094) | T-C----- (24089-24096) | TAC----- (24084-24091) | TAC----- (24089-24096) | TAC----- (24,085-24,092) |
| 4(M) | Body | -------- (24,377-24,384) | -------- (24,435-24,442) | -------- (24,435-24,442) | -------- (24430-24437) | -------- (24,435-24,442) | -------- (24437-24444) | -------- (24429-24436) | -------- (24434-24441) | -------- (24,435-24,442) |
| IR(4bc) | Body | G-C----- (24850-24857) | G-C----- (24905-24912) | G-C----- (24905-24912 | G-C----- (24899-24906) | G-C----- (24934-24941) | G-C----- (24905-24912) | G-C----- (24896-24903) | G-C----- (24896-24903) | G-C----- (24896-24903) |
| 5(5ab) | Body | -------- (25,485-25,492) | -------- (25543-25550) | -------- (25540-25547) | -------- (25538-25545) | -----TAA (25543-25550) | -------- (25545-25552) | -----G-G (25534-25541) | -----G-G (25539-25546) | -----G-G (25,535-25,542) |
| 6(N) | Body | -------- (25,786-25,793) | -------- (25844-25851) | -------- (25841-25848) | -------- (25839-25846) | -------- (25844-25851) | -------- (25846-25854) | -------- (25839-25846) | -------- (25844-25851) | -------- (25,840-25,847) |
| 6b | Body | AGG----- (27,004-27,011) | AAG----- (27,059-27,066) | AGG----- (27,056-27063) | AAG----- (27,053-27060) | AGG----- (27,059-27,066) | AGG----- (27059-27066) | –GG----- (27,054-27,061) | AGG----- (27,054-27061) | AGG----- (27,054-27,061) |
Fig. 1Using the full genome sequences computational recombination analyses were performed with RDP (ver. 4.14; neighbor-joining, Kimura-distance measure method; P < 0.05). Seven algorithms in RDP 4.14, including RDP, GENECONV, Bootscan, MaxChi, Chimaera, SiScan and 3Seq were used to evaluate the recombination events. P values for the Bootscan are represented. The locations of the S1 and S2 genes are represented by the red boxes
Comparison of functional motifs in the spike (S), envelope (E) and membrane (M) proteins
| S | E | M | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Proteolytic cleavage site | ER retention signal | Variable amino acid residue in ectodomain | ||||||||
| S1/S2 | S2’(fusion peptide) | 5 | 6 | 11 | 12 | 13 | 16 | 17 | ||
| KM91 | 534RRFRR/S539a | 688 PSGR/S692a | 103RHGKLHS109b | G | E | S | T | Q | A | E |
| QIA-03342 | 536HRRRR/S541 | 690 PSGR/S694 | -c | - | N | - | E | V | Q | |
| QIA-KR/D79/05 | D | - | - | - | - | - | - | |||
| QIA-Q43/06 | 534RRFRR/S539a | 688 PRRR/S692a | - | - | N | - | E | V | Q | |
| SNU9106 | 536RRFRR/S541 | 690 PSGR/S694 | - | - | - | - | - | - | - | |
| SNU10043 | - | - | - | - | - | - | - | |||
| YX10 | 536HRRRR/S541 | 690 PRGR/S694 | 103RDKLHP108 | E | .d | D | S | E | I | L |
| SNU8065 | E | . | D | S | E | I | L | |||
| SNU11045 | E | . | D | S | E | I | L | |||
aThe different location numbers of KM91 and QIA-Q43/06 are due to the 24G and 25N deletion
bThe different location number is due to an insertion at 105G
cSame amino acid sequence as KM91
dNon-comparable amino acid residue due to 6E insertion
Fig. 3Comparison of the amino acid sequences of each B cell epitope in the IBV spike proteins. Identical amino acids are represented with dots, while deleted amino acids are represented with hyphens. The amino acids unique to KM91 are represented with red letters, and the amino acids unique to each NC1 virus are represented with blue letters. The putative N-linked glycosylation sites are underlined